Biomedical applications of magnetic nanoparticles

Abstract

Magnetic materials have been used with grain sizes down to the nanoscale for longer than any other type of material. This is because of a fundamental change in the magnetic structure of ferro- and ferrimagnetic materials when grain sizes are reduced. In these circumstances, the normal macroscopic domain structure transforms into a single domain state at a critical size which typically lies below 100 nm. Once this transformation occurs the mechanism of magnetisation reversal can only be via the rotation of the magnetisation vector from one magnetic easy axis to another via a magnetically hard direction. This change of reversal mechanism has led to a new class of magnetic materials whose properties and the basic underlying physical mechanism governing them were defined in a seminal work first published by E C Stoner and E P Wolhfarth in 1949.